News from cti A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Apr 23, 2015, 01:30 ET

CTI BioPharma to Report First Quarter 2015 Financial Results on May 6, 2015

CTI BioPharma Corp. (NASDAQ and MTA: CTIC) announced today that it plans to report its first quarter 2015 financial results on Wednesday, May 6,...

Apr 22, 2015, 01:30 ET
CTI BioPharma Corp. Logo

CTI BioPharma and Baxter Announce Phase 3 Data of Pacritinib in Patients with Myelofibrosis to be Presented in Late-Breaking Session at ASCO

 CTI BioPharma Corp. (CTI BioPharma) (NASDAQ and MTA: CTIC) and Baxter International Inc. (NYSE:BAX) today announced that data from the...

Mar 16, 2015, 02:30 ET

CTI BioPharma Announces Publication In Blood Of Phase 2 Results Of Pacritinib In Patients With Myelofibrosis

 CTI BioPharma Corp. (CTI BioPharma) (NASDAQ and MTA: CTIC) today announced that results of a Phase 2 study of pacritinib, in patients with...

Mar 12, 2015, 16:01 ET

CTI BioPharma Reports Fourth Quarter And Full Year 2014 Financial Results

 CTI BioPharma Corp. (NASDAQ and MTA: CTIC) today reported financial results for the fourth quarter and full year ended December 31, 2014....

Mar 09, 2015, 07:00 ET
CTI BioPharma Corp. Logo

CTI BioPharma And Baxter Announce Positive Top-Line Results From Phase 3 Persist-1 Trial Of Pacritinib For Patients With Myelofibrosis

 CTI BioPharma Corp. (CTI BioPharma) (NASDAQ and MTA: CTIC) and Baxter International Inc. (NYSE:BAX) today announced positive top-line results...

Mar 06, 2015, 20:30 ET

CTI BioPharma to Host Conference Call and Webcast on March 9

 CTI BioPharma Corp. (NASDAQ and MTA: CTIC) announced today that its management plans to host a conference call and webcast on Monday, March 9...

Feb 26, 2015, 01:30 ET

CTI BioPharma to Report Fourth Quarter and Full Year 2014 Financial Results on March 12, 2015

CTI BioPharma Corp. (NASDAQ and MTA: CTIC) announced today that it plans to report its fourth quarter and full year 2014 financial results on...

Feb 03, 2015, 01:30 ET

CTI BioPharma Announces Independent DMC Recommendation to Continue GOG-0212 Phase 3 Study of OPAXIO™ as Maintenance Therapy in Ovarian Cancer, an NRG Oncology/GOG Study

 CTI BioPharma Corp. (CTI BioPharma) (NASDAQ and MTA: CTIC) today announced that the Gynecologic Oncology Group, now part of NRG Oncology,...

Jan 12, 2015, 01:30 ET

CTI BioPharma Appoints Alan K. Burnett, M.D. As Therapeutic Area Lead, Myeloid Diseases

CTI BioPharma Corp. (CTI BioPharma) (NASDAQ and MTA: CTIC) announced today the appointment of Alan K. Burnett, M.D., to serve as the strategic...

Jan 08, 2015, 01:30 ET

CTI BioPharma Announces 2015 Outlook and Recent Drug Portfolio Progress

CTI BioPharma Corp. (CTI BioPharma) (NASDAQ and MTA: CTIC) today announced an overview of recent progress for its drug portfolio in addition to...

Dec 09, 2014, 01:30 ET

CTI BioPharma Announces Presentation of Data Demonstrating Pacritinib Overrides Stromal Mediated Resistance in FLT3-ITD Positive AML Cells

CTI BioPharma Corp. (CTI) (NASDAQ and MTA: CTIC) today announced data showing treatment with pacritinib, an investigational oral multikinase...

Dec 06, 2014, 12:00 ET

CTI BioPharma Announces Comprehensive Kinome Analysis that Demonstrates Pacritinib Inhibits Kinases Linked to a Spectrum of Blood-Related Cancers

 CTI BioPharma Corp. (CTI) (NASDAQ and MTA: CTIC) today announced that an analysis of kinase inhibition by pacritinib, a next generation oral...

Dec 04, 2014, 01:30 ET

CTI BioPharma Receives $15 Million Milestone Payment for TRISENOX®

 CTI BioPharma Corp. (CTI) (NASDAQ and MTA: CTIC) today announced that it has received a $15 million milestone payment from Teva Pharmaceutical...

Dec 01, 2014, 01:30 ET

CTI BioPharma Announces Data Presentations at the 56th American Society of Hematology Annual Meeting

CTI BioPharma Corp. (CTI) (NASDAQ and MTA: CTIC) today announced the upcoming presentations of data highlighting pacritinib, an oral multikinase...

Nov 17, 2014, 01:30 ET

CTI BioPharma to Present at the Upcoming Investor Conferences

 CTI BioPharma Corp. (CTI) (NASDAQ and MTA: CTIC) announced today management will present at the following upcoming investor...

Nov 07, 2014, 09:15 ET

CTI BioPharma Prices Underwritten Public Offering of $35 Million of Convertible Preferred Stock

CTI BioPharma Corp. ("CTI") (NASDAQ and MTA: CTIC) today announced the pricing of an underwritten public offering of 35,000 shares of its Series 21...

Nov 06, 2014, 16:15 ET

CTI BioPharma Announces Proposed Public Offering of Convertible Preferred Stock

CTI BioPharma Corp. ("CTI") (NASDAQ and MTA: CTIC) today announced that it intends to offer and sell, subject to market and other conditions,...

Oct 29, 2014, 16:01 ET

CTI BioPharma Reports Third Quarter 2014 Financial Results

CTI BioPharma Corp. (CTI) (NASDAQ and MTA: CTIC) today reported financial results for the three months ended September 30, 2014. "During the...

Oct 27, 2014, 02:30 ET

CTI Acquires Exclusive Worldwide License to Tosedostat, a Selective Oral Anti-Cancer Therapy

CTI BioPharma Corp. (CTI) (NASDAQ and MTA: CTIC) today announced that it has acquired worldwide rights to tosedostat through concurrent...

Oct 20, 2014, 01:30 ET

CTI BioPharma to Report Third Quarter 2014 Financial Results on October 29, 2014

CTI BioPharma Corp. (CTI) (NASDAQ and MTA: CTIC) announced today that it will report its third quarter 2014 financial results on Wednesday, October...